Akums Drugs Q3 Net Profit Jumps 29.5% to Rs 86 Cr, Revenue Hits Rs 1,160 Cr

• Akums Drugs & Pharmaceuticals reported a 29.5% increase in consolidated net profit to Rs 86 crore for Q3 FY25.
• The company's net profit in the October-December quarter of the previous fiscal was Rs 66 crore.
• Revenue for the period rose to Rs 1,160 crore, up from Rs 1,010 crore in the year-ago period.
• Adjusted EBITDA increased 21% year-on-year to Rs 147 crore due to better capacity utilisation and new facilities.
• Tighter overhead control and portfolio rationalisation helped mitigate losses in API and Trade generics segments.